385 filings
Page 5 of 20
6-K
z216ug 4q06
27 Feb 23
SciSparc Signs a Definitive Agreement to Sell 49% interest in its Subsidiary that Owns Wellution for $2.5 million
7:46am
EFFECT
u3ze1
24 Feb 23
Notice of effectiveness
12:15am
CORRESP
c6btw0bg
21 Feb 23
Correspondence with SEC
12:00am
UPLOAD
5wcf8w5cyzx
21 Feb 23
Letter from SEC
12:00am
6-K
cwyx65syccstbhr89ao
17 Feb 23
SciSparc’s Drug Discovery Joint Venture MitoCareX Bio Successfully Reached First Milestone for its Future Machine Learning System
4:05pm
F-3
1mi1lijvhqo 5atx1api
16 Feb 23
Shelf registration (foreign)
6:04pm
6-K
bqitk
16 Feb 23
Report of Foreign Private Issuer
5:24pm
6-K
7xxhqgr
15 Feb 23
SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Three Provisional Patent Applications in the US
8:32am
6-K
28tmlue rdamo
25 Jan 23
SciSparc Announces Corporate Restructuring plan
4:15pm
6-K
81825cr9hmnxkr4 4kw
23 Jan 23
SciSparc to Investigate and Evaluate Concerns of Illegal Trading of its Ordinary Shares
4:10pm
6-K
juvzh2owmdrnpouolz73
18 Jan 23
SciSparc Receives Approval to Conduct its Clinical Trial in Children with Autism Spectrum Disorder at the Soroka Medical Center
4:15pm
6-K
s6ft0xb0rh6tpxd67
9 Jan 23
SciSparc Signs Agreement to Conduct its Clinical Trial in Autism Spectrum Disorder with Soroka Medical Center
4:01pm
6-K
927swcs3k45 gj5x6860
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
6-K
fwjfi8kcx
14 Dec 22
SciSparc Enters Into Non-Binding Letter of Intent to Sell a 50% interest in its Subsidiary that Owns an Amazon Top Seller Brand
4:01pm
6-K
x58 jsm2o148he6
7 Dec 22
SciSparc Announces Positive Study Results with SCI-210, a Cannabidiol-Based Treatment for Epilepsy
1:08pm
6-K
vextg9lx0kyzerh
29 Nov 22
Report of Foreign Private Issuer
12:27pm
6-K
jmdf c4y66
16 Nov 22
SciSparc Enters Into Letter of Intent with an E-commerce Company to Establish a Joint Venture to Market and Develop a New Product Line
4:02pm
6-K
2nw140wz
8 Nov 22
SciSparc Announced Positive Interim Results Meeting Primary Endpoints at Phase IIa Study in Alzheimer’s Disease Patients with Agitation
7:33am
6-K
xly0xjkhdok4ga5vt4
1 Nov 22
Since launch the new product has had approximately 117% ROI
4:00pm
6-K
yglxt2
12 Oct 22
SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification
9:05am